HeXun Biosciences Co., Ltd.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
HeXun’s offerings include allogeneic mesenchymal‑stem‑cell drugs, contract development and manufacturing services (CDMO/CMO), sterile‑filling services, cell and derivative testing and consulting, and a laboratory information‑management system — supported
Founded Year
2019
Unified Business No.
50924393
Status
Active
Number of Employees
46
Total Paid-in
Capital
521,340,000 (NT$)
Location of Company
Taiwan
, Taoyuan City
Exit Status
Emerging Stock Exchange(2023)、OTC listing(2026)
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
HeXun Biosciences Co., Ltd., founded in 2019, is a biotechnology company dedicated to stem‑cell research and therapy, aiming to transform cutting‑edge cellular technologies into high‑quality medical solutions under its core philosophy “LIVE LONG, HEALTHY & HAPPY,” with the mission of improving global human health and well‑being.
